Newborn Opioid Victim Group Says Sackler Releases Justified
A group representing victims of neonatal abstinence syndrome has told the Second Circuit that the benefits those victims will get under opioid maker Purdue Pharma's Chapter 11 plan are large enough...To view the full article, register now.
Already a subscriber? Click here to view full article